MIRA
INFORM REPORT
|
Report Date : |
29th
December, 2006 |
IDENTIFICATION
DETAILS
|
Name : |
EWHA
PHARMTEK CORPORATION |
|
|
|
|
Registered Office : |
245-4, Seoam-ri,
Tongjin-eup, Gimpo-si, Gyeonggi-Do, Korea |
|
|
|
|
Country : |
Korea |
|
|
|
|
Financials (as on) : |
30.12.2004 |
|
|
|
|
Date of Incorporation : |
25.05.1982 |
|
|
|
|
Legal Form : |
Company
Limited by Shares. |
|
|
|
|
Line of Business : |
Manufacture
of Animal Medicaments |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Basic
Information
|
Company Name |
Ewha Pharmtek
Corporation |
|
Address |
245-4, Seoam-ri,
Tongjin-eup, Gimpo-si, GYEONGGI-DO, KOREA |
|
Zip Code |
415-866 |
|
Tel |
+82-31-997-8661 |
|
Fax |
+82-31-997-8667 |
|
E-mail |
ewha@kg21.net, ewha@ewhapharama.com |
|
Website |
www.ewhap.com |
|
Other Address |
San 237-1, Geumgok-dong,
Seo-gu, Incheon 404-330 Korea |
|
Type |
Import |
|
Industry |
Manufacture
of Animal Medicaments |
|
Main Business |
Veterinary
Growth Promoter, Veterinary Anthelmintics, Veterinary Disinfectant, Veterinary
Antibacterial Agents |
|
Established |
05/25/1982 |
Detailed Products
|
Activity |
Detailed
Products (UNSPSC) |
|
Sell |
Cleaning
and disinfecting solutions(47131800) |
|
Sell |
Veterinary
anthelmintics(51102500) |
|
Sell |
Veterinary
products(42121600) |
Others
|
Name |
Lee
Jung-Hyup |
|
Address |
1267, Poong-Dong, Ilsan Dong-Gu, Goyang-Si,
Gyeonggi-Do 410-330 Korea |
|
Date of
Birth |
02/11/1943 |
|
Title |
President & CEO |
|
Sex |
Male |
|
Nationality |
Korean |
|
Capital |
300,000,000 KRW |
|
Employees |
30 |
|
Formation |
Co., Ltd by shares |
The subject deals with the companies in Germany and
France.
The subject is one of leading GMP-producer and
distributor of veterinary products, animal pharmaceuticals and feed additives
in Korea.
Management
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Day |
|
President & CEO |
Mr. |
Lee
Jung-Hyup |
Male |
Korean |
01/07/2000 |
|
Director |
M/S. |
Lee
Mi-Soon |
Female |
Korean |
01/07/2000 |
|
Auditor |
Mr. |
Jeon
Byung-Joon |
Male |
Korean |
03/31/2001 |
Financials
Unit: KRW
|
Year |
Sales |
Assets |
Net income |
|
2005 |
|
|
|
|
2004 |
6,358,000,000 |
5,767,000,000 |
98,000,000 |
|
2003 |
5,641,000,000 |
5,800,000,000 |
161,000,000 |
|
2002 |
|
|
|
Financial Description
Unit: KRW
|
Authorized Capital |
400,000,000 |
||
|
Paid-Up Capital |
300,000,000 |
||
|
Total Issues
Shares |
60,000 |
||
|
|
|||
|
Balance Sheet Unit : Million Korean Won |
|||
|
|
|
Asof12/30/2004 |
Asof12/30/2003 |
|
Total Assets |
|
5,767 |
5,800 |
|
Current
Assets |
|
3,667 |
3,403 |
|
-Quick Assets |
|
2,481 |
2,204 |
|
-Inventories |
|
1,186 |
1,199 |
|
Fixed Assets |
|
2,100 |
2,397 |
|
-Investment |
|
95 |
69 |
|
-Tangibles |
|
2,005 |
2,301 |
|
-Intangibles |
|
- |
27 |
|
Total
Liabilities |
|
3,673 |
3,804 |
|
Current
Liabilities |
|
2,444 |
2,444 |
|
Fixed
Liabilities |
|
1,229 |
1,360 |
|
Capital
Stock |
|
300 |
300 |
|
Capital
Surplus |
|
- |
- |
|
Profit
Surplus |
|
1,794 |
1,696 |
|
Capital
Adjustment |
|
- |
- |
|
Total Equity |
|
2,094 |
1,996 |
|
Liab. &
Shareholder’s Equity |
|
5,767 |
5,800 |
|
|
|||
|
Income Statement Unit : Million Korean
Won |
|||
|
|
|
Asof12/30/2004 |
Asof12/30/2003 |
|
Sales |
|
6,358 |
5,641 |
|
Cost of Sold
Goods |
|
4,147 |
3,306 |
|
Gross Profit |
|
2,211 |
2,335 |
|
Selling & Admin. Expenses |
|
1,972 |
1,999 |
|
Operating
Income |
|
239 |
336 |
|
Non-Operating
Income |
|
74 |
61 |
|
Non-Operating
expenses |
|
192 |
204 |
|
Ordinary
Income |
|
121 |
193 |
|
Special
Income |
|
- |
- |
|
Income
Before Taxes |
|
121 |
193 |
|
Income Taxes
Expenses |
|
23 |
32 |
|
Net Income |
|
98 |
161 |
|
Bank Details |
Industrial Bank of Korea Yeonhee Dong Branch |
||
|
Corporate
Registered No. |
124411-0001222 |
||
|
Business
Registered No. |
136-81-05910 |
||
|
Shareholder
Position |
Lee
Jung-Hyup has 79% of shares. |
||
|
Company History |
05/25/1982 Established |
||
Products, Technologies, Services
Description
|
Main Products & Services |
Pharmaceuticals for large to small animal
veterinarian and practitioner. Feed additive for feed-miller for various species
(e.g. hog, cattle, poultry, fishery) Disinfectant for Animal. Animal market information in Korea Manufacture and Distribution of competitive
product into national and foreign market |
Related Parties (Subsidiaries,
Joint-Venture & Affiliates)
|
Affiliates |
|
|
Overseas
Office |
USA TIMELESS INTERNATIONAL 10525 Lawson River Avenue Fountain Valley, CA
92708 E-mail henrywchung@hotmail.com Tel +1-714-378-2900 Fax +1-714-378-2995 Germany SONNOS TRADE & CONSULTING 60385 Frankfurt / Main E-mail sonnos@t-online.de Tel +1-49-6258-52572 Fax +1-49-6258-52706 |
|
Cooperative
Enterprise |
Interchemie Dyntec Roche Biobe Golschmidt Hoechst |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial
base with the strongest capability for timely payment of interest and
principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded
healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors
carry similar weight in credit consideration. Capability to overcome
financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |
|
NR |
In view of the lack of information, we
have no basis upon which to recommend credit dealings |
No Rating |
|